论文部分内容阅读
目前,心肌梗死的静脉溶栓治疗已得到了充分的肯定,根据我国1991年制定的《急性心肌梗死溶栓疗法参考方案》,将静脉溶栓的年龄限定在65岁以下,时间限定在6小时之内,1996年制定的方案将年龄放宽至70岁以下。高龄急性心肌梗死患者能否进行溶栓治疗,其有效性和安全性如何?发病超过6小时溶栓疗效如何?2000年1月-2003年1月,我们采用重组链激酶(r-SK)溶栓治疗,疗效报告如下。
At present, the intravenous thrombolytic therapy for myocardial infarction has been fully affirmed. According to the “Reference Scheme of Thrombolytic Therapy for Acute Myocardial Infarction” formulated in China in 1991, the age of intravenous thrombolysis is limited to 65 years of age and the time limit is 6 hours The program enacted in 1996 will relax the age to under 70 years of age. Elderly patients with acute myocardial infarction can thrombolytic therapy, the effectiveness and safety of how? More than 6 hours of onset of thrombolytic effect? January 2000 -2003 in January, we use recombinant streptokinase (r-SK) Suppository treatment, the curative effect is reported as follows.